Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Expression of RACK1 is a novel biomarker in pulmonary adenocarcinomas
Lung Cancer, 11/06/09
Nagashio R et al. – The results suggest that RACK1 may be a novel differential diagnostic marker for pulmonary adenocarcinomas.
Related Articles
Use of EGFR/KRAS Mutation Testing To Define Clonal Relationships Among Multiple Lung Adenocarcinomas
Chest, 10/08/09
Relevance Score: 81%
Lung Adenocarcinoma with EGFR Amplification Has Distinct Clinicopathologic and Molecular Features in Never-Smokers
Cancer Research, 11/02/09
Relevance Score: 80%
Diagnostic Efficacy of PET/CT Plus Brain MR Imaging for Detection of Extrathoracic Metastases in Patients with Lung Adenocarcinoma
Journal of Korean Medical Science, 11/16/09
Relevance Score: 69%
Lung cancer: a biologically different disease in women?
Women's Health, 10/30/09
Relevance Score: 68%
An Embryonic Stem Cell–Like Signature Identifies Poorly Differentiated Lung Adenocarcinoma but not Squamous Cell Carcinoma
Clinical Cancer Research, 10/12/09
Relevance Score: 68%
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Detection of Chemerin and It’s Clinical Significance in Peripheral Blood of Patients with Lung Cancer
Chinese Journal of Lung Cancer, 11/25/09
Epothilones in prostate cancer
Urologic Oncology: Seminars and Original Investigations, 11/25/09
Juxtaglomerular cell tumor of the kidney--a new classification scheme
Urologic Oncology: Seminars and Original Investigations, 11/25/09
Sponsor
Article Search
Sponsor


See Latest Articles


